Posts by John

Kymera Therapeutics completes enrollment for its KT-621 trial six months early, marking a major milestone in developing new treatments for atopic dermatitis.

A new clinical trial for rebecsinib offers a breakthrough approach to treating aggressive blood cancers like AML and MDS. Learn about this targeted therapy.

A tragic pediatric death in a Chinese gene-editing trial has reignited global concerns over safety, ethics, and the need for greater clinical transparency.

A new standardized clinical trial framework for Charcot-Marie-Tooth disease aims to speed up drug development and improve treatment outcomes for patients.

Moderna has launched a Phase 1 clinical trial for its mRNA-based Ebola vaccine. Learn how this new approach aims to improve global outbreak response.

African institutions are spearheading Phase 1 trials for a Bundibugyo ebolavirus vaccine, marking a vital step toward regional health security and equity.

Moderna has started Phase 1 clinical trials for an mRNA Ebola vaccine targeting the Sudan strain. Learn about this breakthrough in infectious disease care.

Considering a cancer clinical trial? Learn how to navigate inclusion criteria, the consent process, and key questions to ask your oncologist before joining.

QuantHealth secures $45M in Series B funding to scale its AI-driven clinical trial simulation platform, aimed at reducing drug development risks and costs.

Could semaglutide treat alcohol addiction? New research shows promising reductions in heavy drinking days, suggesting a new path for AUD treatment.